The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Estradiol And Norethindrone Acetate
estradiol and norethindrone acetate · NORETHINDRONE ACETATE .5 mg/1; ESTRADIOL 1 mg/1 · Tablet · Oral · Naari Pte. Limited
NDC 79929-0012-07 · 84 BLISTER PACK in 1 POUCH / 28 TABLET in 1 BLISTER PACK · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for estradiol and norethindrone acetate (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- analysis · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA210233
- TE code
- AB
- Approval date
- Feb 28, 2018
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of estradiol and norethindrone acetate (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| A-S Medication Solutions | ESTRADIOL .5 mg/1; NORETHINDRONE ACETATE .1 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Ingenus Pharmaceuticals, LLC | ESTRADIOL .5 mg/1; NORETHINDRONE ACETATE .1 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Ingenus Pharmaceuticals, LLC | ESTRADIOL 1 mg/1; NORETHINDRONE ACETATE .5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Naari Pte. Limited | NORETHINDRONE ACETATE .5 mg/1; ESTRADIOL 1 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Xiromed LLC | ESTRADIOL .5 mg/1; NORETHINDRONE ACETATE .1 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Xiromed LLC | ESTRADIOL 1 mg/1; NORETHINDRONE ACETATE .5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Naari Pte. Limited | NORETHINDRONE ACETATE 1 mg/1; ESTRADIOL .5 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Naari Pte. Limited | ESTRADIOL 1 mg/1; NORETHINDRONE ACETATE .5 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Estradiol And Norethindrone Acetate — NDC 79929-0012-07," retrieved September 3, 2026, https://drugdashboards.com/drug/79929001207.
Free to cite with attribution — see how the data is put together.